This volume provides unique insights into the field of neuro-oncology by presenting new advancements and research in the study and treatment of tumors of the nervous system, their progression, side effects, and the adverse effects of some therapies. An in-depth exploration of the management of tumors and new therapeutic strategies is extensively covered, including groundbreaking research on gene therapy and molecularly targeted treatments.
Clinicians will gain a better understanding of the many neurological manifestations of tumors through a thorough analysis of recent developments in the field, including new diagnostic imaging techniques. In addition, fresh attention to molecular biology, immunology, and other clinical aspects of these types of tumors is presented.
1. Cover 2. Table of Contents 3. Series Page 4. Copyright 5. Handbook of Clinical Neurology 3rd Series 6. Foreword 7. Preface 8. List of contributors 9. Chapter 29: Low-grade gliomas 10. Chapter 30: Anaplastic astrocytomas 11. Chapter 31: Anaplastic oligodendroglial tumors 12. Chapter 32: Glioblastoma 13. Chapter 33: Gliomatosis cerebri 14. Chapter 34: Primary central nervous system lymphoma 15. Chapter 35: Medulloblastoma and primitive neuroectodermal tumors 16. Chapter 36: Ependymomas, neuronal and mixed neuronal–glial tumors, dysembroblastic neuroepithelial tumors, pleomorphic xanthoastrocytomas, and pilocytic astrocytomas 17. Chapter 37: Neurofibromatosis and other genetic syndromes 18. Chapter 38: Brainstem tumors 19. Chapter 39: Optic, hypothalamic, and thalamic tumors 20. Chapter 40: Pineal parenchymal tumors, embryonal tumors, and germ cell tumors 21. Chapter 41: Tumors of the cerebellopontine angle 22. Chapter 42: Tumors of the meninges 23. Chapter 43: The management of skull base tumors 24. Chapter 44: Peripheral nerve tumors 25. Chapter 45: General oncology and neurological complications 26. Chapter 46: Neurological complications of solid tumors 27. Chapter 47: Neurological complications of leukemia and lymphoma 28. Chapter 48: Neurological complications in plasma cell dyscrasias 29. Chapter 49: Brain metastases 30. Chapter 50: Neoplastic meningitis 31. Chapter 51: Spinal cord involvement 32. Chapter 52: Neuromuscular complications 33. Chapter 53: Neurovascular complications of solid tumors and hematological neoplasms 34. Chapter 54: Infectious, metabolic, and endocrine complications 35. Chapter 55: Central nervous system paraneoplastic disease 36. Chapter 56: Paraneoplastic disorders of the peripheral nervous system 37. Chapter 57: Complications of chemotherapy in neuro-oncology 38. Chapter 58: Complications of radiotherapy to the central nervous system 39. Chapter 59: Neurological complications of chemotherapy to the central nervous system 40. Chapter 60: Neurological complications of chemotherapy to the peripheral nervous system 41. Chapter 61: General and neurological complications of targeted therapy 42. Index
This volume provides unique insights into the field of neuro-oncology by presenting new advancements and research in the study and treatment of tumors of the nervous system, their progression, side effects, and the adverse effects of some therapies. An in-depth exploration of the management of tumors and new therapeutic strategies is extensively covered, including groundbreaking research on gene therapy and molecularly targeted treatments.
Clinicians will gain a better understanding of the many neurological manifestations of tumors through a thorough analysis of recent developments in the field, including new diagnostic imaging techniques. In addition, fresh attention to molecular biology, immunology, and other clinical aspects of these types of tumors is presented.
1. Cover 2. Table of Contents 3. Series Page 4. Copyright 5. Handbook of Clinical Neurology 3rd Series 6. Foreword 7. Preface 8. List of contributors 9. Chapter 29: Low-grade gliomas 10. Chapter 30: Anaplastic astrocytomas 11. Chapter 31: Anaplastic oligodendroglial tumors 12. Chapter 32: Glioblastoma 13. Chapter 33: Gliomatosis cerebri 14. Chapter 34: Primary central nervous system lymphoma 15. Chapter 35: Medulloblastoma and primitive neuroectodermal tumors 16. Chapter 36: Ependymomas, neuronal and mixed neuronal–glial tumors, dysembroblastic neuroepithelial tumors, pleomorphic xanthoastrocytomas, and pilocytic astrocytomas 17. Chapter 37: Neurofibromatosis and other genetic syndromes 18. Chapter 38: Brainstem tumors 19. Chapter 39: Optic, hypothalamic, and thalamic tumors 20. Chapter 40: Pineal parenchymal tumors, embryonal tumors, and germ cell tumors 21. Chapter 41: Tumors of the cerebellopontine angle 22. Chapter 42: Tumors of the meninges 23. Chapter 43: The management of skull base tumors 24. Chapter 44: Peripheral nerve tumors 25. Chapter 45: General oncology and neurological complications 26. Chapter 46: Neurological complications of solid tumors 27. Chapter 47: Neurological complications of leukemia and lymphoma 28. Chapter 48: Neurological complications in plasma cell dyscrasias 29. Chapter 49: Brain metastases 30. Chapter 50: Neoplastic meningitis 31. Chapter 51: Spinal cord involvement 32. Chapter 52: Neuromuscular complications 33. Chapter 53: Neurovascular complications of solid tumors and hematological neoplasms 34. Chapter 54: Infectious, metabolic, and endocrine complications 35. Chapter 55: Central nervous system paraneoplastic disease 36. Chapter 56: Paraneoplastic disorders of the peripheral nervous system 37. Chapter 57: Complications of chemotherapy in neuro-oncology 38. Chapter 58: Complications of radiotherapy to the central nervous system 39. Chapter 59: Neurological complications of chemotherapy to the central nervous system 40. Chapter 60: Neurological complications of chemotherapy to the peripheral nervous system 41. Chapter 61: General and neurological complications of targeted therapy 42. Index
